Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation
Introduction Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endo...
Saved in:
Published in | Angiogenesis (London) Vol. 23; no. 2; pp. 249 - 264 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.05.2020
Springer Nature B.V Springer Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.
Methods and results
To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.
Conclusion
Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders. |
---|---|
AbstractList | Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.INTRODUCTIONAlthough thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.METHODS AND RESULTSTo investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders.CONCLUSIONCollectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders. Introduction Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo. Methods and results To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation. Conclusion Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders. IntroductionAlthough thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.Methods and resultsTo investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.ConclusionCollectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders. INTRODUCTION:Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo.METHODS AND RESULTS:To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation.CONCLUSION:Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders. Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been well-defined in regards to endothelial and vascular function or in post-ischemic revascularisation. We postulated that inhibition of endothelial TXNIP with siRNA or in a Cre-LoxP system could be involved in protection from high fat, high protein, low carbohydrate (HFHPLC) diet-induced oxidative stress and endothelial dysfunction, leading to vascular damage and impaired revascularisation in vivo. To investigate the role of endothelial TXNIP, the TXNIP gene was deleted in endothelial cells using anti-TXNIP siRNA treatment or the Cre-LoxP system. Murine models were fed a HFHPLC diet, known to induce metabolic disorders. Endothelial TXNIP targeting resulted in protection against metabolic disorder-related endothelial oxidative stress and endothelial dysfunction. This protective effect mitigates media cell loss induced by metabolic disorders and hampered metabolic disorder-related vascular dysfunction assessed by aortic reactivity and distensibility. In aortic ring cultures, metabolic disorders impaired vessel sprouting and this alteration was alleviated by deletion of endothelial TXNIP. When subjected to ischemia, mice fed a HFHPLC diet exhibited defective post-ischemic angiogenesis and impaired blood flow recovery in hind limb ischemia. However, reducing endothelial TXNIP rescued metabolic disorder-related impairment of ischemia-induced revascularisation. Collectively, these results show that targeting endothelial TXNIP in metabolic disorders is essential to maintaining endothelial function, vascular function and improving ischemia-induced revascularisation, making TXNIP a potential therapeutic target for therapy of vascular complications related to metabolic disorders. |
Author | Henrion, Daniel Domingues, Alison Smadja, David M. Mignon, Virginie Vessières, Emilie Marquet de Rouge, Perrine Dizier, Blandine Escriou, Virginie Bigey, Pascal Boisson-Vidal, Catherine Chaussain, Catherine Sadoine, Jérémy Nivet-Antoine, Valérie |
Author_xml | – sequence: 1 givenname: Alison surname: Domingues fullname: Domingues, Alison organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris – sequence: 2 givenname: Catherine surname: Boisson-Vidal fullname: Boisson-Vidal, Catherine organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris – sequence: 3 givenname: Perrine surname: Marquet de Rouge fullname: Marquet de Rouge, Perrine organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris – sequence: 4 givenname: Blandine surname: Dizier fullname: Dizier, Blandine organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris – sequence: 5 givenname: Jérémy surname: Sadoine fullname: Sadoine, Jérémy organization: EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, Dental School, Université de Paris – sequence: 6 givenname: Virginie surname: Mignon fullname: Mignon, Virginie organization: PTICM, CNRS, INSERM 3612, Université de Paris – sequence: 7 givenname: Emilie surname: Vessières fullname: Vessières, Emilie organization: CNRS, INSERM 1083, MITOVASC, Université Angers – sequence: 8 givenname: Daniel surname: Henrion fullname: Henrion, Daniel organization: CNRS, INSERM 1083, MITOVASC, Université Angers – sequence: 9 givenname: Virginie surname: Escriou fullname: Escriou, Virginie organization: CNRS, Unité de Technologies Chimiques et Biologiques pour la santé (UTCBS), UMR 8258, INSERM 1022, Université de Paris – sequence: 10 givenname: Pascal surname: Bigey fullname: Bigey, Pascal organization: CNRS, Unité de Technologies Chimiques et Biologiques pour la santé (UTCBS), UMR 8258, INSERM 1022, Université de Paris – sequence: 11 givenname: Catherine surname: Chaussain fullname: Chaussain, Catherine organization: EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, Dental School, Université de Paris, Odontology Department, AP-HP, Bretonneau Hospital – sequence: 12 givenname: David M. surname: Smadja fullname: Smadja, David M. organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, Service d’Hématologie et Laboratoire de Recherches Biochirugicales (Fondation Carpentier), AH-HP, Georges Pompidou European Hospital – sequence: 13 givenname: Valérie surname: Nivet-Antoine fullname: Nivet-Antoine, Valérie email: valerie.nivet-antoine@parisdescartes.fr organization: INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, Clinical Biochemistry Department, AP-HP, Necker Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31900750$$D View this record in MEDLINE/PubMed https://inserm.hal.science/inserm-02429278$$DView record in HAL |
BookMark | eNp9ks1u3CAUha0qVTNJ-wJdVEjdJFJpwX-YZRS1SaRR28VU6g5d4-sZIhumgKPJK_Upy4yTVMoiYoGA7xwul3OSHVlnMcvec_aZMya-BM7KqqaMS8qkYCXdvcoWvBIFFTmTR9mCyVrSOh0dZych3DKWNpryTXZccJkMKrbI_q7ArzEauyZoOxc3OBgYSNwY57FzO2OpsRE96AOz9S6iseRs9fv7zc_zea1jIL13IxkxQusGo0lngvMdeupxgIgdMeMWjB_RRuJ6cgdBTwN40k82GTtLwHZk60KkJugNjsnC4yNlAuyZt9nrHoaA7x7m0-zXt6-ry2u6_HF1c3mxpLoUTaSghRCsgQqLnuk0UjNEVxa8bVvGeJsXDRQlbwC6rm2k4Bp7XUmet00NncyL0-zT7LuBQW29GcHfKwdGXV8slbEB_ahYXuYyF80dT_jZjKde_JkwRDWmN-AwgEU3BZUXRVFzVtd754_P0Fs3eZsek6hGVrxueJWoDw_U1I7YPZXw-GkJyGdAexeCx_4J4Uztk6HmZKiUDHVIhtolUfNMpE089DV6MMPL0mKWhnSPXaP_X_YLqn-qa9F_ |
CitedBy_id | crossref_primary_10_1016_S1875_5364_24_60562_5 crossref_primary_10_1155_2021_6699516 crossref_primary_10_1097_SHK_0000000000001920 crossref_primary_10_1161_CIRCRESAHA_122_321538 crossref_primary_10_1016_j_jare_2023_11_018 crossref_primary_10_3389_fcell_2021_636553 crossref_primary_10_1007_s10456_022_09835_8 crossref_primary_10_1096_fj_202101772R crossref_primary_10_4239_wjd_v12_i12_1979 crossref_primary_10_2174_2589977515666230214101808 crossref_primary_10_1016_j_jare_2024_02_006 crossref_primary_10_1016_j_esxm_2022_100500 crossref_primary_10_1016_j_mvr_2022_104396 crossref_primary_10_1155_2022_7105181 crossref_primary_10_1155_2021_5529810 crossref_primary_10_1161_ATVBAHA_121_316472 crossref_primary_10_3390_ijms22041693 crossref_primary_10_3389_fphys_2021_707634 crossref_primary_10_1186_s13287_024_03850_w crossref_primary_10_1016_j_jhazmat_2022_130623 crossref_primary_10_3389_fphys_2021_700585 crossref_primary_10_1038_s41598_021_96220_y |
Cites_doi | 10.1016/j.stem.2013.10.010 10.1161/ATVBAHA.116.307648 10.1007/s10456-018-9613-x 10.1111/jth.14417 10.1016/j.vph.2017.05.005 10.1371/journal.pmed.0040158 10.1007/s12015-017-9718-4 10.1152/ajpheart.2001.280.6.H2779 10.1177/1479164118793986 10.1016/j.acra.2013.06.003 10.1161/HYPERTENSIONAHA.114.04348 10.1016/j.biocel.2011.09.005 10.1155/2018/6306542 10.1161/RES.0000000000000054 10.1016/j.bbamcr.2007.10.012 10.1016/j.jss.2014.01.020 10.2337/db13-0417 10.1074/jbc.M109.010504 10.1093/gerona/glv071 10.1016/j.freeradbiomed.2010.07.016 10.1161/01.res.0000020401.61826.ea 10.1038/nprot.2011.435 10.1016/j.atherosclerosis.2011.03.038 10.1093/gerona/glt081 10.1016/j.biochi.2010.07.018 10.1126/scisignal.2004235 10.2337/db13-0890 10.1371/journal.pone.0150085 10.1002/dvdy.20643 10.1152/ajpendo.00332.2001 10.1074/jbc.M109.057729 10.1038/s41569-018-0030-z 10.4049/jimmunol.0804221 10.2105/ajph.41.3.279 10.1161/01.RES.0000218193.51136.ad 10.1161/HYPERTENSIONAHA.113.01925 10.1161/CIRCRESAHA.108.188771 10.4049/jimmunol.164.12.6287 10.1097/MCO.0b013e328354a326 10.1016/j.redox.2016.11.002 10.1152/ajpheart.00551.2006 10.1016/j.atherosclerosis.2012.12.015 10.1007/s12015-019-09881-8 10.1073/pnas.0907995106 10.1038/nature04634 10.1038/7434 10.1152/physrev.00006.2013 10.1074/jbc.M400549200 10.1172/JCI44927 10.1160/TH14-09-0748 10.1074/jbc.M112.419101 10.3390/antiox6030047 10.1038/nm740 10.2353/ajpath.2006.060042 10.1002/1873-3468.13156 10.1152/ajpheart.00291.2014 10.1007/978-1-4939-3718-9_8 10.1016/j.numecd.2009.02.011 10.1161/01.res.87.10.840 10.1038/ni.1831 10.1113/jphysiol.2007.143750 10.1161/01.cir.99.24.3188 10.1016/j.nbd.2012.02.008 10.1096/fj.201700856RRR 10.1016/j.jss.2005.06.013 10.1161/HYPERTENSIONAHA.111.181644 |
ContentType | Journal Article |
Copyright | Springer Nature B.V. 2020 Springer Nature B.V. 2020. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: Springer Nature B.V. 2020 – notice: Springer Nature B.V. 2020. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QO 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FR3 FYUFA GHDGH K9. M0S M1P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC |
DOI | 10.1007/s10456-019-09704-x |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Biotechnology Research Abstracts ProQuest Health & Medical Collection (NC LIVE) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Technology Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1573-7209 |
EndPage | 264 |
ExternalDocumentID | oai_HAL_inserm_02429278v1 31900750 10_1007_s10456_019_09704_x |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 203 23M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5VS 67N 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAK LLZTM M1P M4Y MA- N2Q NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM OVD P2P PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOR QOS R89 R9I RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S27 S3A S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7QO 7XB 8FD 8FK ABRTQ FR3 K9. P64 PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 1XC |
ID | FETCH-LOGICAL-c478t-ac77708a5e3f0c0c07207d431bbb001b238a3418aaddb8971cefc5912b86ad923 |
IEDL.DBID | 7X7 |
ISSN | 0969-6970 1573-7209 |
IngestDate | Fri May 09 12:18:21 EDT 2025 Fri Jul 11 05:37:37 EDT 2025 Sat Jul 26 02:26:58 EDT 2025 Thu Apr 03 06:57:25 EDT 2025 Thu Apr 24 22:53:12 EDT 2025 Tue Jul 01 02:35:26 EDT 2025 Fri Feb 21 02:34:41 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Endothelial dysfunction Oxidative stress TXNIP Arterial damage Metabolic disorders Post-ischemic revascularisation |
Language | English |
License | Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c478t-ac77708a5e3f0c0c07207d431bbb001b238a3418aaddb8971cefc5912b86ad923 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7731-9202 0000-0001-5686-9301 0000-0002-5493-455X 0000-0001-6651-4926 0000-0003-1094-0285 0000-0002-3463-3936 |
PMID | 31900750 |
PQID | 2389516815 |
PQPubID | 42475 |
PageCount | 16 |
ParticipantIDs | hal_primary_oai_HAL_inserm_02429278v1 proquest_miscellaneous_2333610662 proquest_journals_2389516815 pubmed_primary_31900750 crossref_primary_10_1007_s10456_019_09704_x crossref_citationtrail_10_1007_s10456_019_09704_x springer_journals_10_1007_s10456_019_09704_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-05-01 |
PublicationDateYYYYMMDD | 2020-05-01 |
PublicationDate_xml | – month: 05 year: 2020 text: 2020-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: Germany |
PublicationTitle | Angiogenesis (London) |
PublicationTitleAbbrev | Angiogenesis |
PublicationTitleAlternate | Angiogenesis |
PublicationYear | 2020 |
Publisher | Springer Netherlands Springer Nature B.V Springer Verlag |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V – name: Springer Verlag |
References | Shireman, Quinones (CR41) 2005; 129 Wu, Ren, Zheng (CR47) 2017; 37 Nowak-Sliwinska, Alitalo, Allen (CR56) 2018; 21 Arruda, Schlegel, Bigey, Escriou (CR38) 2016; 1445 Baker, Robinson, Lechertier (CR43) 2011; 7 Forrester, Seth, Hausladen (CR53) 2009; 284 Csiszar, Ungvari, Edwards (CR17) 2002; 90 Incalza, D'Oria, Natalicchio (CR7) 2018; 100 Sun, Deng, Zhou (CR46) 2018; 2018 Jeong, Piao, Kim (CR37) 2009; 183 Kogata, Arai, Pearson (CR62) 2006; 98 Siu, Li, Zhang (CR49) 2017; 11 Albadawi, Oklu, Cormier (CR11) 2014; 190 Ebrahimian, Heymes, You (CR19) 2006; 169 Kim, Jung, Narasimhan (CR25) 2012; 46 Jia, Sowers (CR8) 2014; 64 Smadja (CR65) 2017; 13 Haddad, Dussault, Groleau (CR20) 2011; 217 Shah, Xia, Goldberg (CR27) 2013; 288 Zhou, Yu, Chng (CR33) 2011; 43 Warren, Ziyad, Briot (CR21) 2014; 7 Nebuloni, Kuhn, Müller (CR42) 2013; 20 Cai, Harrison (CR15) 2000; 87 Alva, Zovein, Monvoisin (CR39) 2006; 235 Moon, Thompson, Madamanchi (CR50) 2001; 280 Zhou, Tardivel, Thorens (CR32) 2010; 11 Couffinhal, Silver, Kearney (CR12) 1999; 99 Richter, Freisinger, Lüders (CR6) 2018; 15 Shin, Jeon, Jeong (CR58) 2008; 1783 Kilani, Gourdou Latyszenok, Guy (CR63) 2019; 17 Yoshioka, Chutkow, Lee (CR40) 2012; 122 Parikh, Carlsson, Chutkow (CR34) 2007; 4 Clifton (CR1) 2009; 19 Hattori, Heissig, Wu (CR54) 2002; 8 Houstis, Rosen, Lander (CR22) 2006; 440 Bedarida, Domingues, Baron (CR31) 2018; 32 Gendron, Thorin-Trescases, Villeneuve, Thorin (CR52) 2007; 292 Cha-Molstad, Saxena, Chen, Shalev (CR44) 2009; 284 Hebert-Schuster, Fabre, Nivet-Antoine (CR23) 2012; 15 Garg, Biggs, Carnethon (CR5) 2014; 63 Farrell, Rogers, Liu (CR57) 2010; 49 Bedarida, Baron, Vessieres (CR2) 2014; 307 Collins, Lyon, Xia (CR16) 2009; 104 Junn, Han, Im (CR24) 2000; 164 Oberacker, Bajorat, Ziola (CR30) 2018; 592 Silvestre, Smadja, Lévy (CR14) 2013; 93 Simons, Alitalo, Annex (CR59) 2015; 116 Elshaer, Mohamed, Coucha (CR36) 2017; 6 Burcelin, Crivelli, Dacosta (CR3) 2002; 282 Dunn, Simpson, Prosser (CR35) 2014; 63 Bedarida, Baron, Vibert (CR26) 2016; 71 Nivet-Antoine, Cottart, Lemaréchal (CR29) 2010; 92 Gaubert, Sigaudo-Roussel, Tartas (CR51) 2007; 585 Foo, Heller, Wykrzykowska (CR4) 2009; 106 Bir, Pattillo, Pardue (CR13) 2014; 63 Rossi, Poirault-Chassac, Bieche (CR66) 2019; 15 Gao, Siu, Chalupsky (CR48) 2012; 59 Schulze, Yoshioka, Takahashi (CR28) 2004; 279 Guerin, Loyer, Vilar (CR64) 2015; 113 Baron, Bedarida, Cottart (CR45) 2014; 69 Dawber, Meadors, Moore (CR9) 1951; 41 Ungvari, Tarantini, Kiss (CR10) 2018; 15 Das, Hatsell, Nannuru (CR60) 2016; 11 Nivet-Antoine, Labat, Shamieh El (CR18) 2013; 227 Takahashi, Kalka, Masuda (CR55) 1999; 5 Joseph, Quach, Walkley (CR61) 2013; 13 V Nivet-Antoine (9704_CR29) 2010; 92 DM Smadja (9704_CR65) 2017; 13 V Nivet-Antoine (9704_CR18) 2013; 227 A Shah (9704_CR27) 2013; 288 R Zhou (9704_CR32) 2010; 11 MT Forrester (9704_CR53) 2009; 284 DC Arruda (9704_CR38) 2016; 1445 NM Das (9704_CR60) 2016; 11 P Clifton (9704_CR1) 2009; 19 SK Moon (9704_CR50) 2001; 280 M Baker (9704_CR43) 2011; 7 T Bedarida (9704_CR26) 2016; 71 B Kilani (9704_CR63) 2019; 17 J Sun (9704_CR46) 2018; 2018 KL Siu (9704_CR49) 2017; 11 J Yoshioka (9704_CR40) 2012; 122 D Shin (9704_CR58) 2008; 1783 P Nowak-Sliwinska (9704_CR56) 2018; 21 P Haddad (9704_CR20) 2011; 217 T Oberacker (9704_CR30) 2018; 592 H Parikh (9704_CR34) 2007; 4 H Cha-Molstad (9704_CR44) 2009; 284 CL Guerin (9704_CR64) 2015; 113 J-S Silvestre (9704_CR14) 2013; 93 M Hebert-Schuster (9704_CR23) 2012; 15 ML Gaubert (9704_CR51) 2007; 585 T Couffinhal (9704_CR12) 1999; 99 J Zhou (9704_CR33) 2011; 43 D Wu (9704_CR47) 2017; 37 S Baron (9704_CR45) 2014; 69 R Burcelin (9704_CR3) 2002; 282 PK Garg (9704_CR5) 2014; 63 T Takahashi (9704_CR55) 1999; 5 M-È Gendron (9704_CR52) 2007; 292 E Rossi (9704_CR66) 2019; 15 AR Collins (9704_CR16) 2009; 104 GS Kim (9704_CR25) 2012; 46 T Bedarida (9704_CR31) 2018; 32 N Houstis (9704_CR22) 2006; 440 SL Elshaer (9704_CR36) 2017; 6 L Nebuloni (9704_CR42) 2013; 20 PC Schulze (9704_CR28) 2004; 279 L Richter (9704_CR6) 2018; 15 G Jia (9704_CR8) 2014; 64 E Junn (9704_CR24) 2000; 164 Z Ungvari (9704_CR10) 2018; 15 M Simons (9704_CR59) 2015; 116 H Albadawi (9704_CR11) 2014; 190 K Hattori (9704_CR54) 2002; 8 T Bedarida (9704_CR2) 2014; 307 SY Foo (9704_CR4) 2009; 106 H Cai (9704_CR15) 2000; 87 MA Incalza (9704_CR7) 2018; 100 TR Dawber (9704_CR9) 1951; 41 JA Alva (9704_CR39) 2006; 235 L Gao (9704_CR48) 2012; 59 SC Bir (9704_CR13) 2014; 63 MR Farrell (9704_CR57) 2010; 49 LL Dunn (9704_CR35) 2014; 63 N Kogata (9704_CR62) 2006; 98 A Csiszar (9704_CR17) 2002; 90 C Joseph (9704_CR61) 2013; 13 CM Warren (9704_CR21) 2014; 7 PK Shireman (9704_CR41) 2005; 129 TG Ebrahimian (9704_CR19) 2006; 169 M Jeong (9704_CR37) 2009; 183 |
References_xml | – volume: 13 start-page: 520 year: 2013 end-page: 533 ident: CR61 article-title: Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.10.010 – volume: 37 start-page: 694 year: 2017 end-page: 706 ident: CR47 article-title: NLRP3 (nucleotide oligomerization domain–like receptor family, pyrin domain containing 3)–caspase-1 inflammasome degrades contractile proteins publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.116.307648 – volume: 21 start-page: 425 year: 2018 end-page: 532 ident: CR56 article-title: Consensus guidelines for the use and interpretation of angiogenesis assays publication-title: Angiogenesis doi: 10.1007/s10456-018-9613-x – volume: 17 start-page: 827 year: 2019 end-page: 840 ident: CR63 article-title: Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells publication-title: J Thromb Haemost doi: 10.1111/jth.14417 – volume: 100 start-page: 1 year: 2018 end-page: 19 ident: CR7 article-title: Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases publication-title: Vasc Pharmacol doi: 10.1016/j.vph.2017.05.005 – volume: 4 start-page: e158 year: 2007 ident: CR34 article-title: TXNIP regulates peripheral glucose metabolism in humans publication-title: PLoS Med doi: 10.1371/journal.pmed.0040158 – volume: 13 start-page: 198 year: 2017 end-page: 201 ident: CR65 article-title: Bone marrow very small embryonic-like stem cells: new generation of autologous cell therapy soon ready for prime time? publication-title: Stem Cell Rev Rep doi: 10.1007/s12015-017-9718-4 – volume: 280 start-page: H2779 year: 2001 end-page: H2788 ident: CR50 article-title: Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.2001.280.6.H2779 – volume: 15 start-page: 504 year: 2018 end-page: 510 ident: CR6 article-title: Impact of diabetes type on treatment and outcome of patients with peripheral artery disease publication-title: Diabetes Vasc Dis Res doi: 10.1177/1479164118793986 – volume: 20 start-page: 1247 year: 2013 end-page: 1255 ident: CR42 article-title: A comparative analysis of water-soluble and blood-pool contrast agents for in vivo vascular imaging with micro-CT publication-title: Acad Radiol doi: 10.1016/j.acra.2013.06.003 – volume: 64 start-page: 1192 year: 2014 end-page: 1193 ident: CR8 article-title: Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.114.04348 – volume: 43 start-page: 1668 year: 2011 end-page: 1673 ident: CR33 article-title: TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2011.09.005 – volume: 2018 start-page: 6306542 year: 2018 end-page: 6306612 ident: CR46 article-title: Endothelium as a potential target for treatment of abdominal aortic aneurysm publication-title: Oxid Med Cell Longev doi: 10.1155/2018/6306542 – volume: 116 start-page: e99 year: 2015 end-page: e132 ident: CR59 article-title: State-of-the-art methods for evaluation of angiogenesis and tissue vascularization: a scientific statement from the American Heart Association publication-title: Circ Res doi: 10.1161/RES.0000000000000054 – volume: 1783 start-page: 838 year: 2008 end-page: 848 ident: CR58 article-title: VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamcr.2007.10.012 – volume: 190 start-page: 683 year: 2014 end-page: 691 ident: CR11 article-title: Hind limb ischemia-reperfusion injury in diet-induced obese mice publication-title: J Surg Res doi: 10.1016/j.jss.2014.01.020 – volume: 63 start-page: 675 year: 2014 end-page: 687 ident: CR35 article-title: A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis publication-title: Diabetes doi: 10.2337/db13-0417 – volume: 284 start-page: 16898 year: 2009 end-page: 16905 ident: CR44 article-title: Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells publication-title: J Biol Chem doi: 10.1074/jbc.M109.010504 – volume: 71 start-page: 720 year: 2016 end-page: 729 ident: CR26 article-title: Resveratrol decreases TXNIP mRNA and protein nuclear expressions with an arterial function improvement in old mice publication-title: J Gerontol A doi: 10.1093/gerona/glv071 – volume: 49 start-page: 1361 year: 2010 end-page: 1367 ident: CR57 article-title: Thioredoxin-interacting protein inhibits hypoxia-inducible factor transcriptional activity publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2010.07.016 – volume: 90 start-page: 1159 year: 2002 end-page: 1166 ident: CR17 article-title: Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function publication-title: Circ Res doi: 10.1161/01.res.0000020401.61826.ea – volume: 7 start-page: 89 year: 2011 end-page: 104 ident: CR43 article-title: Use of the mouse aortic ring assay to study angiogenesis publication-title: Nat Protoc doi: 10.1038/nprot.2011.435 – volume: 217 start-page: 340 year: 2011 end-page: 349 ident: CR20 article-title: Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.03.038 – volume: 69 start-page: 260 year: 2014 end-page: 269 ident: CR45 article-title: Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice publication-title: J Gerontol A doi: 10.1093/gerona/glt081 – volume: 92 start-page: 1766 year: 2010 end-page: 1771 ident: CR29 article-title: Trans-resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion publication-title: Biochimie doi: 10.1016/j.biochi.2010.07.018 – volume: 7 start-page: ra1 year: 2014 ident: CR21 article-title: A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes publication-title: Sci Signal doi: 10.1126/scisignal.2004235 – volume: 63 start-page: 270 year: 2014 end-page: 281 ident: CR13 article-title: Nitrite anion therapy protects against chronic ischemic tissue injury in db/db diabetic mice in a NO/VEGF-dependent manner publication-title: Diabetes doi: 10.2337/db13-0890 – volume: 11 start-page: e0150085 year: 2016 end-page: e0150118 ident: CR60 article-title: In vivo quantitative microcomputed tomographic analysis of vasculature and organs in a normal and diseased mouse model publication-title: PLoS ONE doi: 10.1371/journal.pone.0150085 – volume: 235 start-page: 759 year: 2006 end-page: 767 ident: CR39 article-title: VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells publication-title: Dev Dyn doi: 10.1002/dvdy.20643 – volume: 282 start-page: E834 year: 2002 end-page: E842 ident: CR3 article-title: Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00332.2001 – volume: 284 start-page: 36160 year: 2009 end-page: 36166 ident: CR53 article-title: Thioredoxin-interacting protein (Txnip) is a feedback regulator of S-nitrosylation publication-title: J Biol Chem doi: 10.1074/jbc.M109.057729 – volume: 15 start-page: 555 year: 2018 end-page: 565 ident: CR10 article-title: Endothelial dysfunction and angiogenesis impairment in the ageing vasculature publication-title: Nat Rev Cardiol doi: 10.1038/s41569-018-0030-z – volume: 183 start-page: 2495 year: 2009 end-page: 2505 ident: CR37 article-title: Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions publication-title: J Immunol doi: 10.4049/jimmunol.0804221 – volume: 41 start-page: 279 year: 1951 end-page: 281 ident: CR9 article-title: Epidemiological approaches to heart disease: the Framingham Study publication-title: Am J Public Health Nations Health doi: 10.2105/ajph.41.3.279 – volume: 98 start-page: 897 year: 2006 end-page: 904 ident: CR62 article-title: Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization publication-title: Circ Res doi: 10.1161/01.RES.0000218193.51136.ad – volume: 63 start-page: 413 year: 2014 end-page: 419 ident: CR5 article-title: Metabolic syndrome and risk of incident peripheral artery disease publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.113.01925 – volume: 104 start-page: e42 year: 2009 end-page: e54 ident: CR16 article-title: Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes publication-title: Circ Res doi: 10.1161/CIRCRESAHA.108.188771 – volume: 164 start-page: 6287 year: 2000 end-page: 6295 ident: CR24 article-title: Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function publication-title: J Immunol doi: 10.4049/jimmunol.164.12.6287 – volume: 15 start-page: 397 year: 2012 end-page: 402 ident: CR23 article-title: Catalase polymorphisms and metabolic diseases publication-title: Curr Opin Clin Nutr Metab Care doi: 10.1097/MCO.0b013e328354a326 – volume: 11 start-page: 118 year: 2017 end-page: 125 ident: CR49 article-title: NOX isoforms in the development of abdominal aortic aneurysm publication-title: Redox Biol doi: 10.1016/j.redox.2016.11.002 – volume: 292 start-page: H451 year: 2007 end-page: H458 ident: CR52 article-title: Aging associated with mild dyslipidemia reveals that COX-2 preserves dilation despite endothelial dysfunction publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00551.2006 – volume: 227 start-page: 100 year: 2013 end-page: 105 ident: CR18 article-title: Relationship between catalase haplotype and arterial aging publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.12.015 – volume: 15 start-page: 590 year: 2019 end-page: 600 ident: CR66 article-title: Human endothelial colony forming cells express intracellular CD133 that modulates their vasculogenic properties publication-title: Stem Cell Rev Rep doi: 10.1007/s12015-019-09881-8 – volume: 106 start-page: 15418 year: 2009 end-page: 15423 ident: CR4 article-title: Vascular effects of a low-carbohydrate high-protein diet publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0907995106 – volume: 440 start-page: 944 year: 2006 end-page: 948 ident: CR22 article-title: Reactive oxygen species have a causal role in multiple forms of insulin resistance publication-title: Nature doi: 10.1038/nature04634 – volume: 5 start-page: 434 year: 1999 end-page: 438 ident: CR55 article-title: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization publication-title: Nat Med doi: 10.1038/7434 – volume: 93 start-page: 1743 year: 2013 end-page: 1802 ident: CR14 article-title: Postischemic revascularization: from cellular and molecular mechanisms to clinical applications publication-title: Physiol Rev doi: 10.1152/physrev.00006.2013 – volume: 279 start-page: 30369 year: 2004 end-page: 30374 ident: CR28 article-title: Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein publication-title: J Biol Chem doi: 10.1074/jbc.M400549200 – volume: 122 start-page: 267 year: 2012 end-page: 279 ident: CR40 article-title: Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury publication-title: J Clin Investig doi: 10.1172/JCI44927 – volume: 113 start-page: 1084 year: 2015 end-page: 1094 ident: CR64 article-title: Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential publication-title: Thromb Haemost doi: 10.1160/TH14-09-0748 – volume: 288 start-page: 6835 year: 2013 end-page: 6848 ident: CR27 article-title: Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells publication-title: J Biol Chem doi: 10.1074/jbc.M112.419101 – volume: 6 start-page: E47 year: 2017 ident: CR36 article-title: Deletion of TXNIP mitigates high-fat diet-impaired angiogenesis and prevents inflammation in a mouse model of critical limb ischemia publication-title: Antioxidants doi: 10.3390/antiox6030047 – volume: 8 start-page: 841 year: 2002 end-page: 849 ident: CR54 article-title: Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment publication-title: Nat Med doi: 10.1038/nm740 – volume: 169 start-page: 719 year: 2006 end-page: 728 ident: CR19 article-title: NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes publication-title: Am J Pathol doi: 10.2353/ajpath.2006.060042 – volume: 592 start-page: 2297 year: 2018 end-page: 2307 ident: CR30 article-title: Enhanced expression of thioredoxin-interacting-protein regulates oxidative DNA damage and aging publication-title: FEBS Lett doi: 10.1002/1873-3468.13156 – volume: 307 start-page: H649 year: 2014 end-page: H657 ident: CR2 article-title: High-protein-low-carbohydrate diet: deleterious metabolic and cardiovascular effects depend on age publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00291.2014 – volume: 1445 start-page: 137 year: 2016 end-page: 148 ident: CR38 article-title: Lipoplexes strengthened by anionic polymers: easy preparation of highly effective siRNA vectors based on cationic lipids and anionic polymers publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-3718-9_8 – volume: 19 start-page: 379 year: 2009 end-page: 382 ident: CR1 article-title: High protein diets and weight control publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2009.02.011 – volume: 87 start-page: 840 year: 2000 end-page: 844 ident: CR15 article-title: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress publication-title: Circ Res doi: 10.1161/01.res.87.10.840 – volume: 11 start-page: 136 year: 2010 end-page: 140 ident: CR32 article-title: Thioredoxin-interacting protein links oxidative stress to inflammasome activation publication-title: Nature Immunol doi: 10.1038/ni.1831 – volume: 585 start-page: 617 year: 2007 end-page: 626 ident: CR51 article-title: Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice publication-title: J Physiol doi: 10.1113/jphysiol.2007.143750 – volume: 99 start-page: 3188 year: 1999 end-page: 3198 ident: CR12 article-title: Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice publication-title: Circulation doi: 10.1161/01.cir.99.24.3188 – volume: 46 start-page: 440 year: 2012 end-page: 449 ident: CR25 article-title: Induction of thioredoxin-interacting protein is mediated by oxidative stress, calcium, and glucose after brain injury in mice publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2012.02.008 – volume: 32 start-page: 3108 year: 2018 end-page: 3118 ident: CR31 article-title: Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo publication-title: FASEB J doi: 10.1096/fj.201700856RRR – volume: 129 start-page: 242 year: 2005 end-page: 250 ident: CR41 article-title: Differential necrosis despite similar perfusion in mouse strains after ischemia publication-title: J Surg Res doi: 10.1016/j.jss.2005.06.013 – volume: 59 start-page: 158 year: 2012 end-page: 166 ident: CR48 article-title: Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.111.181644 – volume: 41 start-page: 279 year: 1951 ident: 9704_CR9 publication-title: Am J Public Health Nations Health doi: 10.2105/ajph.41.3.279 – volume: 5 start-page: 434 year: 1999 ident: 9704_CR55 publication-title: Nat Med doi: 10.1038/7434 – volume: 63 start-page: 675 year: 2014 ident: 9704_CR35 publication-title: Diabetes doi: 10.2337/db13-0417 – volume: 15 start-page: 590 year: 2019 ident: 9704_CR66 publication-title: Stem Cell Rev Rep doi: 10.1007/s12015-019-09881-8 – volume: 6 start-page: E47 year: 2017 ident: 9704_CR36 publication-title: Antioxidants doi: 10.3390/antiox6030047 – volume: 59 start-page: 158 year: 2012 ident: 9704_CR48 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.111.181644 – volume: 11 start-page: 118 year: 2017 ident: 9704_CR49 publication-title: Redox Biol doi: 10.1016/j.redox.2016.11.002 – volume: 227 start-page: 100 year: 2013 ident: 9704_CR18 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2012.12.015 – volume: 284 start-page: 16898 year: 2009 ident: 9704_CR44 publication-title: J Biol Chem doi: 10.1074/jbc.M109.010504 – volume: 13 start-page: 520 year: 2013 ident: 9704_CR61 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.10.010 – volume: 164 start-page: 6287 year: 2000 ident: 9704_CR24 publication-title: J Immunol doi: 10.4049/jimmunol.164.12.6287 – volume: 13 start-page: 198 year: 2017 ident: 9704_CR65 publication-title: Stem Cell Rev Rep doi: 10.1007/s12015-017-9718-4 – volume: 49 start-page: 1361 year: 2010 ident: 9704_CR57 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2010.07.016 – volume: 46 start-page: 440 year: 2012 ident: 9704_CR25 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2012.02.008 – volume: 100 start-page: 1 year: 2018 ident: 9704_CR7 publication-title: Vasc Pharmacol doi: 10.1016/j.vph.2017.05.005 – volume: 235 start-page: 759 year: 2006 ident: 9704_CR39 publication-title: Dev Dyn doi: 10.1002/dvdy.20643 – volume: 217 start-page: 340 year: 2011 ident: 9704_CR20 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.03.038 – volume: 585 start-page: 617 year: 2007 ident: 9704_CR51 publication-title: J Physiol doi: 10.1113/jphysiol.2007.143750 – volume: 11 start-page: e0150085 year: 2016 ident: 9704_CR60 publication-title: PLoS ONE doi: 10.1371/journal.pone.0150085 – volume: 99 start-page: 3188 year: 1999 ident: 9704_CR12 publication-title: Circulation doi: 10.1161/01.cir.99.24.3188 – volume: 183 start-page: 2495 year: 2009 ident: 9704_CR37 publication-title: J Immunol doi: 10.4049/jimmunol.0804221 – volume: 20 start-page: 1247 year: 2013 ident: 9704_CR42 publication-title: Acad Radiol doi: 10.1016/j.acra.2013.06.003 – volume: 116 start-page: e99 year: 2015 ident: 9704_CR59 publication-title: Circ Res doi: 10.1161/RES.0000000000000054 – volume: 15 start-page: 504 year: 2018 ident: 9704_CR6 publication-title: Diabetes Vasc Dis Res doi: 10.1177/1479164118793986 – volume: 43 start-page: 1668 year: 2011 ident: 9704_CR33 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2011.09.005 – volume: 282 start-page: E834 year: 2002 ident: 9704_CR3 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00332.2001 – volume: 106 start-page: 15418 year: 2009 ident: 9704_CR4 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0907995106 – volume: 190 start-page: 683 year: 2014 ident: 9704_CR11 publication-title: J Surg Res doi: 10.1016/j.jss.2014.01.020 – volume: 4 start-page: e158 year: 2007 ident: 9704_CR34 publication-title: PLoS Med doi: 10.1371/journal.pmed.0040158 – volume: 92 start-page: 1766 year: 2010 ident: 9704_CR29 publication-title: Biochimie doi: 10.1016/j.biochi.2010.07.018 – volume: 122 start-page: 267 year: 2012 ident: 9704_CR40 publication-title: J Clin Investig doi: 10.1172/JCI44927 – volume: 11 start-page: 136 year: 2010 ident: 9704_CR32 publication-title: Nature Immunol doi: 10.1038/ni.1831 – volume: 307 start-page: H649 year: 2014 ident: 9704_CR2 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00291.2014 – volume: 63 start-page: 270 year: 2014 ident: 9704_CR13 publication-title: Diabetes doi: 10.2337/db13-0890 – volume: 93 start-page: 1743 year: 2013 ident: 9704_CR14 publication-title: Physiol Rev doi: 10.1152/physrev.00006.2013 – volume: 279 start-page: 30369 year: 2004 ident: 9704_CR28 publication-title: J Biol Chem doi: 10.1074/jbc.M400549200 – volume: 19 start-page: 379 year: 2009 ident: 9704_CR1 publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2009.02.011 – volume: 64 start-page: 1192 year: 2014 ident: 9704_CR8 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.114.04348 – volume: 280 start-page: H2779 year: 2001 ident: 9704_CR50 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.2001.280.6.H2779 – volume: 90 start-page: 1159 year: 2002 ident: 9704_CR17 publication-title: Circ Res doi: 10.1161/01.res.0000020401.61826.ea – volume: 17 start-page: 827 year: 2019 ident: 9704_CR63 publication-title: J Thromb Haemost doi: 10.1111/jth.14417 – volume: 37 start-page: 694 year: 2017 ident: 9704_CR47 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.116.307648 – volume: 21 start-page: 425 year: 2018 ident: 9704_CR56 publication-title: Angiogenesis doi: 10.1007/s10456-018-9613-x – volume: 104 start-page: e42 year: 2009 ident: 9704_CR16 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.108.188771 – volume: 440 start-page: 944 year: 2006 ident: 9704_CR22 publication-title: Nature doi: 10.1038/nature04634 – volume: 288 start-page: 6835 year: 2013 ident: 9704_CR27 publication-title: J Biol Chem doi: 10.1074/jbc.M112.419101 – volume: 15 start-page: 555 year: 2018 ident: 9704_CR10 publication-title: Nat Rev Cardiol doi: 10.1038/s41569-018-0030-z – volume: 169 start-page: 719 year: 2006 ident: 9704_CR19 publication-title: Am J Pathol doi: 10.2353/ajpath.2006.060042 – volume: 69 start-page: 260 year: 2014 ident: 9704_CR45 publication-title: J Gerontol A doi: 10.1093/gerona/glt081 – volume: 2018 start-page: 6306542 year: 2018 ident: 9704_CR46 publication-title: Oxid Med Cell Longev doi: 10.1155/2018/6306542 – volume: 1783 start-page: 838 year: 2008 ident: 9704_CR58 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamcr.2007.10.012 – volume: 8 start-page: 841 year: 2002 ident: 9704_CR54 publication-title: Nat Med doi: 10.1038/nm740 – volume: 592 start-page: 2297 year: 2018 ident: 9704_CR30 publication-title: FEBS Lett doi: 10.1002/1873-3468.13156 – volume: 7 start-page: ra1 year: 2014 ident: 9704_CR21 publication-title: Sci Signal doi: 10.1126/scisignal.2004235 – volume: 284 start-page: 36160 year: 2009 ident: 9704_CR53 publication-title: J Biol Chem doi: 10.1074/jbc.M109.057729 – volume: 7 start-page: 89 year: 2011 ident: 9704_CR43 publication-title: Nat Protoc doi: 10.1038/nprot.2011.435 – volume: 292 start-page: H451 year: 2007 ident: 9704_CR52 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00551.2006 – volume: 63 start-page: 413 year: 2014 ident: 9704_CR5 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.113.01925 – volume: 71 start-page: 720 year: 2016 ident: 9704_CR26 publication-title: J Gerontol A doi: 10.1093/gerona/glv071 – volume: 1445 start-page: 137 year: 2016 ident: 9704_CR38 publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-3718-9_8 – volume: 98 start-page: 897 year: 2006 ident: 9704_CR62 publication-title: Circ Res doi: 10.1161/01.RES.0000218193.51136.ad – volume: 129 start-page: 242 year: 2005 ident: 9704_CR41 publication-title: J Surg Res doi: 10.1016/j.jss.2005.06.013 – volume: 87 start-page: 840 year: 2000 ident: 9704_CR15 publication-title: Circ Res doi: 10.1161/01.res.87.10.840 – volume: 15 start-page: 397 year: 2012 ident: 9704_CR23 publication-title: Curr Opin Clin Nutr Metab Care doi: 10.1097/MCO.0b013e328354a326 – volume: 113 start-page: 1084 year: 2015 ident: 9704_CR64 publication-title: Thromb Haemost doi: 10.1160/TH14-09-0748 – volume: 32 start-page: 3108 year: 2018 ident: 9704_CR31 publication-title: FASEB J doi: 10.1096/fj.201700856RRR |
SSID | ssj0009684 |
Score | 2.3835776 |
Snippet | Introduction
Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not... Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not been... IntroductionAlthough thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not... INTRODUCTION:Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biological functions, the contribution of endothelial TXNIP has not... |
SourceID | hal proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 249 |
SubjectTerms | Angiogenesis Animal models Animals Aorta Biomedical and Life Sciences Biomedicine Blood flow Blood vessels Cancer Research Carbohydrates Cardiology Cardiology and cardiovascular system Carrier Proteins - genetics Cell Biology Cells, Cultured Cellular Biology Complications Cytoprotection - genetics Diet Endothelial cells Endothelial Cells - physiology High carbohydrate diet High protein diet Hindlimb - blood supply Human health and pathology Impairment In vivo methods and tests Ischemia Ischemia - genetics Ischemia - metabolism Ischemia - physiopathology Ischemia - prevention & control Life Sciences Low carbohydrate diet Low protein diet Male Metabolic Diseases - complications Metabolic Diseases - genetics Metabolic Diseases - metabolism Metabolic Diseases - physiopathology Metabolic disorders Mice Mice, Inbred C57BL Mice, Knockout Neovascularization, Physiologic - genetics Nutrient deficiency Oncology Ophthalmology Original Paper Oxidative stress Oxidative Stress - physiology Proteins siRNA Subcellular Processes Therapeutic applications Thioredoxin Thioredoxins - genetics |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Rb9MwELZgSIgXNDZgYQMZCRAILMVpYjuPFWIqCCYeWqlvke04WqTWmdoMjb-0X7k712lBAyRUKX3o5ZLqznef7e_OhLyCpK1LyDssdxouqYY4KGzK7KhUjbOZ4xu2xZmYzPIv82Iei8LWA9t92JIMkfqXYjdI9jD1RYqPTHMGyPFeAXN3JHLNsvGu1a4I5wzDd8kESMZSmT_r-C0d3T1HMuRtpHlrlzQkn9N98jCiRjremPkRueP8ATkce5gxL3_SNzTwOMMC-QG5_y1ulx-S62ngeYNK6nyNtVYLcDfan7cd9gm9aj3DdhGhUApkQs-G1tO30_nZ5-_vaOzhsKZYg0KXrgeHWbSW1rFjJwuFMK6mWGrZrnCdkXYNHcitFHMm2p1qX9OLbt2zFubSyManKzdIRTrRYzI7_TT9OGHxcAZmc6l6pq2UMlW6cKMmtfCRWSprgCPGIBAzAAU0ZEilIYAaVUpuXWOLkmdGCV0DrHxC9nzn3RGhptamkVpwm5e5dMYUlnPUr0BrkxYJ4YONKhs7l-MBGotq13MZ7VqBXatg1-oqIe-391xs-nb8U_o1mH4riC23J-OvVeshDCwrhDFlJtUPnpCTwTmqONbXFfxT8HihOLzoy-3PMEpx60V7112izGgEQFWILCFPN061fRoEwQDcEvJh8LKd8r-_87P_Ez8mDzJcKghczROy168u3XPAU715EYbPDRyqGf0 priority: 102 providerName: Springer Nature |
Title | Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation |
URI | https://link.springer.com/article/10.1007/s10456-019-09704-x https://www.ncbi.nlm.nih.gov/pubmed/31900750 https://www.proquest.com/docview/2389516815 https://www.proquest.com/docview/2333610662 https://inserm.hal.science/inserm-02429278 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9NAEB68OxC_iN75Eu88VlBRdDFJk2zySar0rG_lkBbqp7C72XCBNum1Oal_yV_pzHbTIodHIYFmOg3M7Mzs7MwzAM_RacsM_Q6PjMSLL9EOJtrnupelpdGhCTbVFqNkOIm-TOOpS7itXFllZxOtoS4aTTnyd-hakG-SBvH7xSWnqVF0uupGaOzBAUGXkVaLqdiB7iZ24jDeM55kwndNM651DkMH3EhTwZDwI77-xzHtXVBZ5PWY89p5qXVDZ_fgrosfWX8j8Ptwy9SHcNSvce88_81eMlvRaVPlh3D7uzs4P4I_Y1vxjSyZqQvqupqh4rH2omoIMXRd1ZyAI2zLFNJY9IaqZq_G09Hn89fMoTmsGHWjsLlpUXVmlWaFw-7ktiXGFIyaLqslZRxZU7KuzJWR9yQNYLIu2KJZtbzCXTXV5bOl6ahcYdEDmJwNxh-H3I1p4DoSaculFkL4qYxNr_Q1fkToiwIDE6UoJFMoOYm-MpVoSlWaiUCbUsdZEKo0kQUGmA9hv25q8xiYKqQqhUwCHWWRMErFOgiIf4pcSz_2IOhklGuHYU6jNGb5Dn2Z5JqjXHMr13ztwZvtbxYbBI8bqV-g6LeEBL497H_LqxoNwjyngCYLRfor8OCkU47crfpVvtNRD55tH-N6pUMYWZvmimh6PQxZkyT04NFGqbb_hubQhnAevO20bMf8_-_85OZ3OYY7ISUJbJXmCey3yyvzFCOpVp3a5XIKB_1PP78O8P5hMDr_gd9Owv5fUXsgpw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB6VIkEvCFqghgKLRBEIVtiO7bUPCEVAldA04pBKuW3X67VqKbFD4kL6Shx4RmY2diJU0VtlKT5kPLY0s_OzO_MNwCt02ipBv8MDo_DHVWgHI-1y3Uni3GjfeKtqi2HUOw2-jcPxFvxpe2GorLK1idZQZ5WmPfIP6FqQbxR74afZD05To-h0tR2hsVKLY3P5C1O2xcf-F5Tvoe8ffR197vFmqgDXgYhrrrQQwo1VaDq5q_ESvisy9KNpShFEii9SaNpjhSs_jRPhaZPrMPH8NI5UlhDQAZr82_iAS8meGIsNyG9kJxzjPeFRItymSadp1cNQBRN3KlASbsCX_zjCW-dUhnk1xr1yPmvd3tF9uNfEq6y7UrAHsGXKXdjrlpirTy_Za2YrSO3W_C7cOWkO6vfg98hWmCNLZsqMurwmqOisPi8qQihdFiUnoArbooU0Fi2iKNmb0XjY__6WNegRC0bdL2xqalTVSaFZ1mCFctuCYzJGTZ7FnHY4WZWztqyWkbcmjWOqzNisWtS8wCye-gDY3LRUTSHTQzi9EQE-gu2yKs0-sDRTaS5U5OkgCYRJ01B7HvGPkWvuhg54rYykbjDTaXTHRG7QnkmuEuUqrVzl0oF362dmK8SQa6kPUfRrQgL77nUHsijRAE0lBVCJL-KfngMHrXLIxsos5GZNOPBy_TfaBzr0UaWpLoim08EQOYp8Bx6vlGr9NjS_NmR04H2rZRvm___mJ9d_ywu42xudDOSgPzx-Cjs-bVDYCtED2K7nF-YZRnF1-twuHQZnN71W_wJ4kFld |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB6VVKq4IGj5MRRYJIpA1Krt2F77gFCgjRJaogilUm5mvV6rlhI7JC6kr8Qj8HTMbNaJUEVvVSTn4PHY0szOz-7MNwCv0WmLGP2O7SuBF0egHQylY8t2HOVKespdVVsMwt65_2UcjLfgT9MLQ2WVjU3UhjqrJO2RH6FrQb5h5AZHuSmLGB53P85-2DRBik5am3EaKxU5VVe_MH1bfOgfo6wPPK97Mvrcs82EAVv6PKptITnnTiQC1c4diT_uOTxDn5qmFE2k-FKBZj4SaAXSKOauVLkMYtdLo1BkMYEeoPnf5pQVtWD708lg-G0D-Rvqecf4H9thzB3TsmMa9zBwwTSeypW449vLf9zinQsqyrwe8V47rdVOsHsf7pnolXVW6vYAtlS5C3udEjP36RV7w3Q9qd6o34Wdr-bYfg9-j3S9ObJkqsyo52uCas_qi6IivNJlUdoEW6EbtpBGY0cUJXs7Gg_6w3fMYEksGPXCsKmqUXEnhWSZQQ61dUOOyhi1fBZz2u9kVc6aIltGvpv0j4kyY7NqUdsF5vTUFcDmqqEyZU0P4fxWRPgIWmVVqifA0kykORehK_3Y5ypNA-m6xD9CrrkTWOA2MkqkQVCnQR6TZIP9THJNUK6JlmuytOD9-pnZCj_kRuoDFP2akKC_e52zpCjRHE0TCqdij0c_XQv2G-VIjM1ZJJsVYsGr9W20FnQEJEpVXRJNu40Bcxh6FjxeKdX6bWiMdQBpwWGjZRvm___mpzd_y0vYwXWanPUHp8_grke7FbpcdB9a9fxSPceQrk5fmLXD4PttL9e_d-he-A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+endothelial+thioredoxin-interacting+protein+%28TXNIP%29+protects+from+metabolic+disorder-related+impairment+of+vascular+function+and+post-ischemic+revascularisation&rft.jtitle=Angiogenesis+%28London%29&rft.au=Domingues%2C+Alison&rft.au=Boisson-Vidal%2C+Catherine&rft.au=Marquet+de+Rouge%2C+Perrine&rft.au=Dizier%2C+Blandine&rft.date=2020-05-01&rft.issn=0969-6970&rft.eissn=1573-7209&rft.volume=23&rft.issue=2&rft.spage=249&rft.epage=264&rft_id=info:doi/10.1007%2Fs10456-019-09704-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10456_019_09704_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0969-6970&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0969-6970&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0969-6970&client=summon |